Vous êtes ici

Novamind Inc.

Novamind Inc.
Liste d'échange: 
CSE
Statut: 
Delisted
Industrie: 
Diversified Industries
Symbole: 
NM
Indice CSE: 
Devise: 

Novamind is a leading mental health company enabling safe access to psychedelic medicine through a network of clinics and clinical research sites. Novamind provides ketamine-assisted psychotherapy and other novel treatments through its network of integrative mental health clinics and operates a full-service contract research organization specialized in clinical trials and evidence-based research for psychedelic medicine. For more information on how Novamind is enhancing mental wellness and guiding people through their entire healing journey, visit www.novamind.ca.

Vous êtes ici

Novamind Inc. (NM)

SEDAR Information

Information d'entreprise

Addresse
150 King St. West, Suite 202
toronto, ON M5H 1J9
Canada
Téléphone
(647) 953 9512
Courriel
[email protected]
URL
http://www.novamind.ca
Date d’inscription à la cote
Mardi, janvier 5, 2021
Agent de transfert
Marrelli Trust Company Limited
Relations avec les investisseurs
Bill Mitoulas
Courriel
[email protected]
Vérificateur
DMCL LLP

Capitalisation

Capitalisation: 
54927163
Réservé à l'émission: 
22915883

Company Officers

Yaron Conforti, Chief Executive Officer
Dr. Reid Robison, Chief Medical Officer
Dr. Paul Thielking, Chief Scientific Officer
Prakash Gowd, Chief Operating Officer
Jing Peng, Chief Financial Officer and Corporate Secretary

Bulletins

13/06/2022

2022-0618 - Radiation -Novamind Inc. (NM)

le 13 juin/June 2022